Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Return on Equity (2020 - 2025)

Vivos Therapeutics has reported Return on Equity over the past 6 years, most recently at 0.41% for Q4 2025.

  • Quarterly Return on Equity fell 39.0% to 0.41% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.41% through Dec 2025, down 39.0% year-over-year, with the annual reading at 0.07% for FY2025, 4.0% down from the prior year.
  • Return on Equity was 0.41% for Q4 2025 at Vivos Therapeutics, down from 0.05% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.08% in Q3 2023 and troughed at 0.59% in Q4 2023.
  • The 5-year median for Return on Equity is 0.01% (2021), against an average of 0.07%.
  • Year-over-year, Return on Equity tumbled -59bps in 2023 and then surged 58bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then surged by 1962bps to 0.0% in 2022, then crashed by -440107bps to 0.59% in 2023, then skyrocketed by 98bps to 0.01% in 2024, then plummeted by -2758bps to 0.41% in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Return on Equity are 0.41% (Q4 2025), 0.05% (Q3 2025), and 0.03% (Q2 2025).